Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting

Summary

Argatroban is a selective thrombin inhibitor, and previous study had suggested that argatroban use post PCI could potentially prevent reocclusion. But there has no study on large sample of argatroban treated restenosis post cranial stenting. This study will test the safety and efficacy of the argatroban on prevent occlusion and restenosis in patients with intracranial and extracranial artery stenting.

Timeline

Start

2010-08

Primary completion

2013-12

Completion

2014-08

Drugs

Indications